Ph2 Study of Savolitinib and Durvalumab (MEDI4736) Combination in Advanced MET Amplified Gastric Cancer(VIKTORY-2)

Clinical trial NCT05620628 · RECRUITING

Trial details

NCT number: NCT05620628
Sponsor: Jeeyun Lee
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Stomach Cancer, Adenocarcinoma

Start date: 2023-01-05
Primary completion: 2026-12-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.